ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Weaning Patients Off of PPIs

by Amy E. Hamaker • October 14, 2016

  • Tweet
  • Email
Print-Friendly Version

Introduced in the 1970s for use in reducing gastric acid production, proton pump inhibitors (PPIs) are among the most widely sold drugs in the world; omeprazole appears on the World Health Organization Model List of Essential Medicines. They are used in treating conditions such as gastroesophageal reflux disease (GERD), dyspepsia, reflux esophagitis, peptic ulcer disease (PUD), and hypersecretory conditions (e.g., Zollinger-Ellisson Syndrome), and are included as part of the eradication therapy for Helicobacter pylori bacteria (Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No. CD011969. doi: 10.1002/14651858.CD011969).

You Might Also Like

  • Some Laryngopharyngeal Reflux Resists PPI Treatment
  • Reviewers ID Reflux Disease Clinical Guidelines
  • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
  • High BMI a Significant Indicator of PPI Weaning Failure
Explore This Issue
October 2016

PPIs are also commonly used on a long-term basis for preventing esophagitis caused by laryngopharyngeal reflux (LPR). PPIs are effective at reducing gastric acid, but researchers have noted the potential for harm that comes from long-term prescription-level use, including an increased risk of bone fractures not found with short-term, low-dose use. The U.S. Food and Drug Administration included a warning on PPI drug labels in 2010, noting that the available data show that patients at the highest risk for fractures received high doses of prescription PPIs and/or used a PPI for one year or more, but decided against adding a warning label to over-the-counter versions.

Alongside an increase in bone fracture risk, long-term high-dose PPIs carry other risks, including the possibility of interference with the absorption of iron, calcium, magnesium and vitamin B-12 due to a reduction in the breakdown of micronutrients released by gastric acid (Curr Gastroenterol Rep. 2010;12: 448–457). Long-term use has also been associated with an increased risk of pneumonia and Clostridium difficile colitis, according to the Cochrane Report.

This raises an important question for clinicians who see patients with LPR: How do you assess whether a patient should be on PPIs on a long-term basis, and how do you wean them off of the medication if necessary?

Why Wean?

As PPI use becomes ever more common, it is important to note that some patients may not need them as part of a regular regimen—a recent study noted that up to 50% of PPI users are inappropriately prescribed the medication (Ann Pharmacother. 2015;49:29-38).

Part of the problem is that while LPR symptoms differ from GERD symptoms in that LPR doesn’t usually include heartburn and regurgitation, the symptoms that are most frequently reported in LPR (mild hoarseness and the need to clear the throat, globus, post-nasal drip, chronic cough, difficulty swallowing, sore throat, and an irritated, swollen larynx) are nonspecific and may be due to other factors such as allergy, smoking, environmental irritants, infection, or vocal abuse (Am J Otolaryngol. 2016;37:245-250). The researchers who conducted the study reported on in Annals of Pharmacotherapy also noted that 22% to 70% of patients who are prescribed a PPI do not have an appropriate indication for it.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider, Laryngology, Practice Focus Tagged With: deprescribing, PPI, proton pump inhibitorIssue: October 2016

You Might Also Like:

  • Some Laryngopharyngeal Reflux Resists PPI Treatment
  • Reviewers ID Reflux Disease Clinical Guidelines
  • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
  • High BMI a Significant Indicator of PPI Weaning Failure

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.